Eli Lilly News

Eli Lilly and Company Release: Fifth Lilly Oncology on Canvas Art Competition Invites All Touched by Cancer to Share Their Cancer Journeys /PRNewswire/ -- Get your canvases, paintbrushes and cameras ready the subject is cancer and you are the storyteller.

At 8 a.m.: New unemployment claims continue to fall. Last week 357,000 people filed for unemployment.

Recent earnings reports from a few bellwethers in the pharmaceutical space suggest that more pain is likely ahead for the beleaguered industry.

Cisco, the world's largest maker of computer networking equipment, on Wednesday said its net income jumped 44 percent in the latest quarter as it continues to put last year's slump behind it.

Bend Research Inc. , a leading independent drug-formulation development and manufacturing company, announced today that it has entered into a licensing agreement with Eli Lilly and Company.

Jim assembled an experienced management team and Scientific Advisory Board to progress lasmiditan through clinical development to become a Phase 3-ready compound.

AMAG Pharmaceuticals, Inc. today announced the appointment of Rajiv De Silva and Gino Santini to its board of directors, effective immediately.

Even with the stock market rally of the past year there are still solid dividend paying stocks available.

INDIANAPOLIS, Feb. 7, 2012 /PRNewswire/ -- Eli Lilly and Company announced today that a Phase III study, published online by European Urology, showed both CialisA and tamsulosin significantly improved scores on the International Prostate Symptom Score , compared to placebo, in men with signs and symptoms suggestive of benign prostatic hyperplasia .

If a drugmaker could cut coupons, Eli Lilly would be doing so. Because of "the business challenges the company faces," this year many of its top staffers and executives will not be receiving their usual annual boosts to base salaries, according to a filing made late last week with the US Securities and Exchange Commission.

Amidst all the uncertainty in the markets, investors are struggling with being in cash or trying to find some safe defensive plays that will be able to weather the storm.

SAN DIEGO &#8212 Diabetes drug maker Amylin Pharmaceuticals Inc. reported a larger fourth-quarter loss Monday after it ended a partnership with Eli Lilly & Co., which gave Amylin all the rights to the drug Byetta and newly approved Bydureon.

The best way to diversify your portfolio remains a very questionable debate. The answer typically depends upon your assessment of risk/reward. However, one belief that almost everyone can agree upon is that diversifying a portfolio with various investments is the smartest, and safest, way to invest.

Eli Lilly & Co. will freeze base pay for most of its employees in 2012, citing financial pressures caused by patent expirations on top drugs.

Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.

Lilly CEO's compensation dropped about 1% last year The top executive at Eli Lilly and Co.

The top executive at Eli Lilly and Co. saw his total compensation dip about 1 percent last year, during a challenging period in which the company lost patent protection on its largest product and profits fell 27 percent.

Eli Lilly & Co. will freeze salaries for most employees worldwide this year, as sales of its best- selling drug declined faster than expected after losing patent protection.

Major Pharmaceutical companies have seen their profits drop in recent quarters as patent protection on their largest products continues to shrink revenues.

For drugmakers, the golden era of the 1990s and early part of the last decade, when they seemed to effortlessly churn out new multibillion-dollar pills for the masses along with double-digit quarterly profit increases, is not even in the rearview mirror any more.